Your browser doesn't support javascript.
loading
Myricetin ameliorates sepsis-associated acute lung injury in a murine sepsis model.
Xu, Haibo; Qi, Qian; Yan, Xixin.
Affiliation
  • Xu H; Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, 215 West Heping Road, Shijiazhuang, 050000, Hebei, People's Republic of China.
  • Qi Q; Department of Forensic Pathology, College of Forensic Medicine, Hebei Medical University, Shijiazhuang, 050017, Hebei, People's Republic of China.
  • Yan X; Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, 215 West Heping Road, Shijiazhuang, 050000, Hebei, People's Republic of China. yanxixin2020@hb2h.com.
Naunyn Schmiedebergs Arch Pharmacol ; 394(1): 165-175, 2021 01.
Article in En | MEDLINE | ID: mdl-32458011

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Flavonoids / Sepsis / Protective Agents / Acute Lung Injury / Anti-Inflammatory Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2021 Document type: Article Country of publication: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Flavonoids / Sepsis / Protective Agents / Acute Lung Injury / Anti-Inflammatory Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2021 Document type: Article Country of publication: Alemania